Screener
Amneal Pharmaceuticals, Inc. AMRX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current portion of operating lease liabilities - related party | 2,899 | 2,705 |
| Current portion of financing lease liabilities | 3,521 | 3,442 |
| Related party payables - short term | 22,070 | 55,485 |
| Total current liabilities | 883,187 | 881,633 |
| Long-term debt, net | 2,564,335 | 2,565,115 |
| Operating lease liabilities | 38,691 | 33,233 |
| Operating lease liabilities - related party | 12,712 | 14,195 |
| Financing lease liabilities | 54,602 | 54,927 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s total current liabilities?
- Amneal Pharmaceuticals, Inc. (AMRX) reported total current liabilities of $883.19M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s total current liabilities changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s total current liabilities decreased by 20.2% year-over-year, from $1.11B to $883.19M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s total current liabilities has grown at a 5.4% compound annual growth rate (CAGR), from $676.9M to $881.63M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Amneal Pharmaceuticals, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude